NCT05454124

Brief Summary

A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function, and preservation of sight. The comparison of different training and outcome factors is in line with the NIMH RDOC framework and studies in an aging population are consistent with the mission of the NIA.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Nov 2022Nov 2026

First Submitted

Initial submission to the registry

July 5, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 12, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

4 years

First QC Date

July 5, 2022

Last Update Submit

February 4, 2026

Conditions

Keywords

plasticitycentral vision lossperceptual learning

Outcome Measures

Primary Outcomes (3)

  • Change from Baseline Radial Bias from the Crowding Task after completion of Training at approximately 7 weeks

    The ratio of the crowding threshold along the axis connected to the fovea vs. along the orthogonal axis.

    Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average

  • Change from Baseline Saccadic Precision after Completion of Training at approximately 7 weeks

    Consistency across trials in placement of the first saccade calculated by the distribution across trials (bivariate contour ellipse area) of the landing point of the first fixation of each trial.

    Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average

  • Change from Baseline Fixation Stability after Completion of Training at approximately 7 weeks

    Normalizing fixations in the PRL to the first fixation to that region and calculating the distribution of all fixation locations in this normalized space (measured as a bivariate contour ellipse area).

    Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average

Other Outcomes (18)

  • Change from Baseline Acuity after Completion of Training at approximately 7 weeks

    Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average

  • Change from Baseline Contrast Sensitivity after Completion of Training at approximately 7 weeks

    Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average

  • Change from Baseline Minimal print size from the MNREAD task after Completion of Training at approximately 7 weeks

    Baseline and Within 3 weeks of training completion, training is complete 7 weeks from baseline on average

  • +15 more other outcomes

Study Arms (2)

Training visual sensitivity

EXPERIMENTAL

A standard Perceptual Learning approach to train early visual processes of discriminating the orientation of Gabor patches presented at threshold- level contrast. Preliminary data, using this method, in normally seeing and MD participants show both feasibility and preliminary evidence that this training gives rise to improvements in acuity.

Behavioral: Training visual sensitivity

Combination training

EXPERIMENTAL

In combination training, investigators test the extent to which a combined training gives rise to the joint benefits of each training individually, or integrative benefits potentially surpassing benefits of the individual training alone. The visual sensitivity task will alternate across blocks with the spatial integration task, using the timing of targets and location switches from spatial attention training.

Behavioral: Combination training

Interventions

Investigators adopt a standard PL approach to train early visual processes of discriminating the orientation of Gabor patches presented at threshold contrast. Across training blocks, Gabors will range in spatial frequency, where contrast is adapted with a 3/1 staircase. Whenever a specific contrast threshold is reached, spatial frequency will increase by 2 cycles per degree and contrast will be reset. Preliminary data from this method in normally seeing and MD participants show both feasibility and tentative evidence that this training gives rise to improvements in acuity.

Training visual sensitivity

Daily tasks involve a combination of being sensitive to basic visual features, being able to integrate these features, and directing attention and eye movements to better evaluate the information of potential interest. To address this integrative nature of real-world vision, this condition combines elements of training visual sensitivity, spatial integration, and spatial attention.

Combination training

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-89
  • Severely impaired vision in both eyes (20/100 or worse)
  • diagnosis of Macular Degeneration by an Ophthalmologist
  • Light sensitivity in the macular retina that is at least 10 dB units worse than in peripheral regions, as demonstrated by a scanning laser ophthalmoscope (MAIA)
  • Medical record review indicating this level of disease severity has been present for at least 2 years
  • Reside within 50 miles of study site

You may not qualify if:

  • Pacemaker or any ferromagnetic metal implanted in their body
  • Metal of any type implanted in their head (limited dental work is acceptable)
  • Claustrophobia
  • Being hearing-impaired
  • Weight over 300 pounds
  • Maximum body girth over 60 inches
  • Previous serious head injury
  • Presence of hallucinations or delusions
  • Excessive old, or colorful tattoos, especially near the head
  • Pregnancy
  • Braces/permanent retainer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UAB

Birmingham, Alabama, 35294, United States

RECRUITING

MeSH Terms

Conditions

Blindness, CorticalMacular DegenerationScotoma

Condition Hierarchy (Ancestors)

BlindnessVision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsRetinal DegenerationRetinal Diseases

Central Study Contacts

Rachel A Chua, MS

CONTACT

Kristina M Visscher, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 5, 2022

First Posted

July 12, 2022

Study Start

November 1, 2022

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

February 9, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Results of the project will be submitted to the relevant repository (ClinicalTrials.gov, or Open-ScienceFramework, MRI data to OpenfMRI) within one year of the final participant completing data collection. The investigators expect to report participant flow by group (intervention or control), participant demographics (age, sex assigned at birth, years of education), outcome measures and statistical analyses, adverse events (if applicable), and limitations or caveats of our results. The investigators also will ensure that the final protocol and statistical analysis code are uploaded to the record. No Protected Health Information will be shared.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
Within one year of the final participant completing data collection.

Locations